Full Text (PDF)
Case Report

An Atypical Case of Myxedema Coma with Incidental Chilaiditi Syndrome

Raghwesh Ojha, Sonika Dhillon, Raghwesh Ojha

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Emergency Medicine 9(4):p 205-208, October-December 2023. | DOI: 10.21088/ijem.2395.311X.9423.7

How Cite This Article:

Dhillon S, Ojha R. An atypical case of myxedema coma with incidental Chilaiditi syndrome. Indian J Emerg Med. 2023;9(4):205-8.

Timeline

Received : April 01, 2023         Accepted : May 31, 2023          Published : June 09, 2023

Abstract

• Hypothyroidism is a prevalent condition in the general population.1 42 million people in India have thyroid disorders and hypothyroidism is the most common, affecting one in ten adults.

• Myxedema coma is a rare and life threatening emergency with a high mortality rate.2 It results from severe hypothyroidism and affects almost every organ

• Patients will present with myxedema coma, characterized by hypothermia, hypotension, bradycardia, and altered mental status in the setting of severe hypothyroidism.3 Myxedema coma has also been known to manifest in a number of unusual and dangerous forms.

• A high index of suspicions is needed among clinicians in order to rapidly recognize the condition and make an early diagnosis. Treatment should be commenced on clinical grounds while waiting for laboratory results.

• Here, we present the case of a male who presented to the emergency department with altered mental status, Anasarca and in abilty to walk.
 


References

  • 1.   Patel P, Bekkerman M, Varallo-Rodriguez C, Rampersaud R. An atypical case of myxedema coma with concomitant nonconvulsive seizure. Case Rep Crit Care. 2016;2016:3438080.
  • 2.   Ito H, Fukuda K, Ashida K, Nagayama A, Sako T, Mizuochi K, et al. Case Report: Myxedema Coma Caused by Immunoglobulin A Vasculitis in a Patient With Severe Hypothyroidism. Front Immunol. 2022;13:838739.
  • 3.   Beynon J, Akhtar S, Kearney T. Predictors of outcome in myxoedema coma. Crit Care. 2008;12:111.
  • 4.   Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician. 2000;62(11):2485-90.
  • 5.   Maldonado D, Patel U, Tarlin N. A case of refractory myxedema coma. Cureus. 2020;12(8):e9737.
  • 6.   Elkattawy S, Dhanoa P, Kotys J, Fichadiya H, Eckman A. Myxedema coma: case report and literature review. Cureus. 2021;13(5):e15277.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects.

Acknowledgements

Information not provided.

Conflicts of Interest

The authors report no conflicts of interest in this work.


About this article


Cite this article

Dhillon S, Ojha R. An atypical case of myxedema coma with incidental Chilaiditi syndrome. Indian J Emerg Med. 2023;9(4):205-8.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
April 01, 2023 May 31, 2023 June 09, 2023

DOI: 10.21088/ijem.2395.311X.9423.7

Keywords

MyxedemaHypothyroidismHypothermiaHypercapneaLevothyroxine

Article Level Metrics

Last Updated

Tuesday 07 July 2026, 12:38:52 (IST)


2530

Accesses

8
890
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received April 01, 2023
Accepted May 31, 2023
Published June 09, 2023

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share